Lectures and seminars Faculty event: Isabell Brikell

Title

Understanding medication treatment discontinuation in ADHD: multi-national epidemiological and genomic analyses 

Abstract 

ADHD is common neurodevelopmental disorder which onsets in childhood and often persists into adulthood. ADHD medication have proven effective in reducing ADHD core symptoms and observational studies show that continued treatment is associated with reduced risk of serious real-world outcomes. Despite this, a large proportion of individuals with ADHD discontinue medication pre-maturely, yet reasons are not well-understood. In this talk, I will present our ongoing and planned multi-national epidemiological and genomic (GWAS, whole exome sequencing and polygenic scores analyses) analyses of treatment discontinuation in ADHD.

About the speaker 

Isabell Brikell is an Assistant Professor at MEB working at the intersection of psychiatric-, genetic- and pharmaco- epidemiology to increase knowledge about clinical heterogeneity in ADHD and related neuropsychiatric conditions. Her current research focuses on identifying clinical, sociodemographic and genetic factors associated with treatment discontinuation in ADHD; neurological comorbidity in ADHD;  and etiology and comorbidity in Borderline personality disorder. She received her PhD in psychiatric epidemiology from MEB in 2018 and has since worked as postdoc at Aarhus University and the Department of Global Public Health and Primary Care, University of Bergen, where she currently holds joint positions with MEB.

Join the faculty event in Wargentin! After the seminar, the faculty lunch will be served in Ljusgården.